#35. Santhi Analytis: Innovation & Branding for a Consumer Product

Innovation & Branding for a Consumer Product


Santhi Analytis, PhD, CTO & Co-Founder, Moxxly


Santhi Analytis (née Elayaperumal) is CTO and co-founder of Moxxly, Inc., a San Francisco based consumer tech company designing products for women. Moxxly’s first product is an FDA-cleared breast pump system for today’s mobile mom. Moxxly was acquired by Olle Larsson Holding, the parent of Medela and Bravado.

This episode was recorded early this year, and since then, Moxxly has merged with its sister company and stopped selling the Flow online.

Santhi holds a BBmE degree from the University of Minnesota, and earned her MS and PhD in Mechanical Engineering at Stanford University as an NSF Graduate Research Program Fellow. Her PhD thesis, “Technologies for Needle Manipulation in MRI-Guided Interventions,” involved building fiber optic strain and force sensing tools, haptic manipulators, and surgical navigation systems. Santhi helped modernize the curriculum of an international, industry-sponsored graduate design course at Stanford, by creating the module “Paper Robot”, which introduced students to mechatronic prototyping. Her contribution was integrated as a core component of the course and is still used today.

Her work experience includes verifying a percutaneous heart valve replacement (Sadra Medical, acquired by Boston Scientific), and evaluating localization sensors for a robotic catheter system (Hansen Medical). She has designed for the developing world (Engineering World Health, iDE), and collaborated with Kodak and Panasonic on consumer tech projects.

Santhi was a mentor for the FIRST Robotics League and has directed interactive art projects focusing on brainwave-based sound and visual installations. Her brain machine interface robots have been shown in exhibits and galleries around the Bay Area.

#34. Lisa Suennen: Leadership by Women in Healthtech

Leadership by Women in Healthtech


Lisa Suennen, Leader, Manatt Digital & Technology

Lisa Suennen headshot 6.16.14.jpeg

Lisa Suennen is the leader of Manatt Digital and Technology and the firm’s venture capital / emerging companies practice. With more than 30 years’ experience as an entrepreneur, venture capitalist, board member and strategic advisor, she has focused broadly on new technologies and how they are transforming businesses. She has spent much of her career helping companies adopt and leverage digital technologies, develop strategies for growth through innovation and investment, and build strong collaborations between established players and entrepreneurs. Lisa heads the firm’s digital and technology businesses as well as the firm’s venture capital fund. She also works closely with Manatt Health, engaging with payers, health systems and companies to provide strategic advice on innovation, digital strategy and growth.

Lisa previously served as managing partner of Venture Valkyrie LLC, an advisory firm focused on helping healthcare organizations adopt venture capital and innovation programs and develop new business creation models and digital health strategies.

Lisa spent the past 20 years as a venture capitalist, first as a partner with Psilos Group, then leading the healthcare fund at GE Ventures. Prior to that, she was part of the leadership team that built Merit Behavioral Care, an $800 million behavioral healthcare company, guiding it through its successful IPO and exit. Her earlier career focused on product management and marketing in the technology sector.

Lisa currently serves on several private company boards and chairs the advisory board of the NASA-funded Translational Research Institute for Space Health. She is also on the faculty at the UC Berkeley Haas School of Business, and is cofounder of CSweetener, which matches women in and nearing the healthcare C-suite with mentors.

Additionally, Lisa writes the Venture Valkyrie blog and hosts the Tech Tonics podcast.

#33. Kareem Barghouti: Cancer Immunology & the Microbiome

Cancer Immunology & the Microbiome


Kareem Barghouti, Co-Founder, VastBiome

Kareem_Headshot .jpg

Kareem Barghouti is the co-founder and CEO of VastBiome. He received his B.S. in Biological Sciences at UC Irvine and an MBA from Duke University with a concentration in Healthcare Sector Management. His background is in Strategy & Operations and Sales & Marketing. Early in his Kareem joined the fast-growing startup Wildfire Interactive as an Account Executive which was acquired by Google. He spent 5 years at Google leading the data integrity of Google’s advertising business, managing vendor teams of 100+, and was part of the core product team to launch an online education portal to millions of users globally. He was recognized as the top sales rep globally (1000+ reps) for the New Business Sales team. Before Google, he co-founded an online marketplace (StingyCampus.com), having raised $250K in seed funding and launched the program across 12 universities in Southern California. Most recently, Kareem participated as a Biodesign Fellow at the Texas Medical Center Innovation Institute in Houston, Texas, where VastBiome was born. He now works full-time on VastBiome, located in the Bay Area. Personal interests include long distance running, having been an NCAA Division I Cross Country and Track & Field athlete.

#32. Rachel Kuperman: Predicting Epileptic Seizures in Children

Predicting Epileptic Seizures in Children


Rachel Kuperman, MD, CEO, Eysz, Inc.

kuperman sq 200.jpg

During Dr. Kuperman's 10 years at UCSF Benioff Children's Hospital, Oakland, she developed the epilepsy program by focusing on excellence in clinical care, and research. She stepped back to focus on developing Eysz. Eysz comes out of her clinical work to help parents, caregivers and physicians quantitate the burdens of epilepsy: seizures, side effects and cognitive effects. The goal of Eysz is to improve the lives of people with epilepsy by leaving no seizure, side effect or complication undetected.

#31. Holly Rockweiler: A Non-Hormonal Treatment for Vaginal Dryness

A Non-Hormonal Treatment for Vaginal Dryness


About Holly Rockweiler


Holly Rockweiler is co-founder and CEO of Madorra, a women’s health company dedicated to changing the treatment paradigm for vaginal dryness.

Rockweiler co-founded Madorra three years ago as a spin-out of the Stanford Biodesign Fellowship. Prior to Biodesign, she worked as a senior research scientist in the Cardiac Rhythm Management division of Boston Scientific. There, she co-developed a new sensing algorithm for cardiac resynchronization therapy that enables more efficient care for patients living with heart failure. Her work has led to 15 pending and issued patents. Rockweiler holds a Master of Science and a Bachelor of Science in biomedical engineering from Washington University in St. Louis.

#30. Matt Likens: Preventing Brain Cancer Recurrence with GammaTiles

Preventing Brain Cancer Recurrence with GammaTiles


About Matt Likens

04.14.15 Photo of Matthew Likens.jpg

Matt Likens is currently president and CEO of GT Medical Technologies, Inc., inventors of Gammatile(TM) Therapy, with a corporate purpose of "Improving the Lives of Patients with Brain Tumors". Previously, he held the same position at Ulthera, Inc., which grew from start-up to over $100M in revenue before being sold to Merz Pharma in July, 2014, for $600M. Prior to that, Matt began his career at J&J before spending the bulk of his career at Baxter Healthcare International, where he held ascending levels of responsibility, culminating in positions as President Biotech North America and President of Renal Dialysis in the U.S. He is a board member of privately-held Luma Therapeutics where they are commercializing their novel and effective approach to use UV light and coal tar patches to treat psoriasis, and publicly-traded CHF Solutions, which sells the AquaDex System to effectively reduce fluid overload in patients. He is a past winner of the Ernst &Young Mountain and Desert Region Entrepreneur of the Year award, is an active member of the Greater Phoenix Economic Council Healthcare Advisory Committee, and also is a member of the City of Mesa Economic Development Council. Matt remains active with his alma mater, Kent State University as a member of their College of Business Administration Advisory Board.

#29. Dorna Hakimi: Bootstrapping Resorbable Drug Delivery at Bioinspire

Bootstrapping Resorbable Drug Delivery at Bioinspire


About Dorna Hakimi


Dorna Hakimi, PhD, is founder and CEO of BioInspire Technologies, a Palo Alto startup whose core technology is a bioresorbable, biocompatible medical film that can deliver therapies to specific locations.

BioInspire has developed a flexible, therapeutic film made of human plasma fibrinogen, a naturally occurring protein. The film can be easily placed on surface tissue or delivered to a remote tissue using non-invasive delivery tools.

Originally from Iran, Dorna completed a PhD at the University of British Columbia. While a graduate student, she began working at MIV Therapeutics, where she continued after earning her doctorate. She held positions at Medlogics Device Corporation and Osseon Therapeutics before founding BioInspire in 2009.

#28. Caroline Corner: How to Position Your Story for Financial Audiences

How to Position Your Story for Financial Audiences


Caroline Corner, PhD, Managing Partner, Westwicke Partners


Caroline Corner, Ph.D., joined Westwicke Partners in 2016 as a Managing Director leading our San Francisco effort in Medical Technology. Caroline’s focus is working with both public and private companies in the medical device and diagnostics areas. Her expertise and extensive C-level industry relationships stem from more than 12 years working in sell-side equity research, various roles within device and healthcare companies, as well as her academic training in biochemistry, engineering and nanobiotechnology.

#27. Niquette Hunt: Candesant's Topical Device to Treat Excessive Sweating

Candesant's Topical Device to Treat Excessive Sweating


Niquette Hunt, CEO, Candesant Biomedical


Niquette Hunt, CEO, has over twenty-five years’ experience in developing, launching and commercializing 20+ products across multiple verticals in the consumer medicine market. Every business she managed increased sales, profits and/or market share. Before founding Candesant, Ms. Hunt charted the commercial strategy at Revance Therapeutics and helped raise over $250 million in the 2014 IPO and follow-on financing.

#26. Steve Axelrod: Wirelessly Monitoring the GI Tract at G-Tech Medical

Wirelessly Monitoring the GI Tract at G-Tech Medical


Steve Axelrod, PhD, President & CEO, G-Tech Medical

Fogarty-0889 300px.jpg

Steve received his Ph.D. from Yale in Elementary Particle Physics and did his post-doc in the same field at Stanford. He worked at Measurex-Honeywell for 15 years where he was Director of Measurement System and Hardware Engineering. In 2003 he entered the medical device field, and helped develop and commercialize the Xoft Axxent microTube and radiation therapy delivery system. Steve has led teams delivering numerous best in class systems and devices in both medical devices and industrial automation. Some examples are nuclear basis weight, X-ray and infrared absorption sensors, Large scanning frames, fast high channel count data acquisition systems, skin and vaginal applicators for radiation therapy, high precision measurement systems for characterizing and testing system and device performance. Steve has been CEO of G-Tech since November 2011. This project combines his experience leading high performance R&D teams, his passion for medical devices and his expertise in creating sophisticated measurement systems.

#25. Jonathan Coe: Making the Switch from Engineer to CEO at Prescient

Making the Switch from Engineer to CEO at Prescient


Jonathan Coe, Co-Founder, President & CEO, Prescient Surgical

Jonathan Coe-17-2S.jpg

With more than a decade of experience in the medical device industry, Jon is both an inventor and a leader. Before co-founding Prescient Surgical as a Stanford Biodesign Innovation Fellow, Jon held a range of roles in engineering, marketing, and leadership in the surgical instrument divisions of Johnson & Johnson and Covidien. He is an inventor on 25 issued patents and successfully launched four major products in bariatric, general, and natural orifice surgery, and surgical oncology. He also started two interventional cardiology companies, Metavention and Gradient Therapeutics, and led the IP, technical, and pre-clinical efforts at Metavention through a successful Series B investment. Jon holds SB and MS degrees in Mechanical Engineering from MIT and Georgia Tech, respectively.

#24. Shubhra Jain: How We Invest at Cota Capital

How We Invest at Cota Capital


Shubhra Jain, MD, Senior Associate, Cota Capital


Dr. Shubhra Jain joined Cota in 2018 as a Senior Associate where she is responsible for sourcing, executing and analyzing healthcare investments. Prior to Cota, Shubhra was Associate Director of Commercial Strategy and Corporate Development at Natera where she focused on Biopharma Partnerships, the diligence of potential acquisitions, market research and competitive positioning. Prior to Natera, she led Product management for Acute care suite of products at Pieces Technologies where she led product development and launch of SaaS risk surveillance and prediction solutions for clinical outcomes and published peer-reviewed research on the subject. Prior to Pieces, Dr. Jain served as a consultant and an advisor to several health tech startups and Fortune 500 companies.

Dr. Jain is a Primary Care Physician from India, has her Masters in Engineering from Stanford with a major in Biodesign and her MBA from the Wharton School of Business.

#23. Ryan Pierce: How to Get Funded

How to Get Funded


Ryan Pierce, Co-Founder and CEO, Nine, & Lecturer in Bioengineering, Stanford

pierce headshot.jpg

This is a recording of a live event. View the presentation deck

Ryan Pierce is Co-Founder and CEO of Nine, Entrepreneur-in-Residence at Rock Health, and Lecturer in Bioengineering at Stanford, where he teaches BIOE 70Q: Medical Device Innovation. He has served as VP of Design and Innovation at Ventus Medical, VP of Business Development at Loma Vista Medical, a healthcare investor at De Novo Ventures, and a product designer at Concentric Medical and The Foundry/Zephyr Medical. An inventor on over two dozen issued U.S. patents, he has designed FDA-cleared devices to treat sleep apnea and stroke. Ryan holds mechanical engineering degrees from MIT and Stanford, and an MBA from Harvard Business School.

#22. Mike Harrison: Pioneering Fetal Surgery

Pioneering Fetal Surgery


Michael R. Harrison, MD

Principal Investigator & Clinical Lead, UCSF-Stanford Pediatric Device Consortium

Professor Emeritus of Surgery, Pediatrics, Obstetrics, Gynecology & Reproductive Sciences, UCSF

Director Emeritus, UCSF Fetal Treatment Center

Since retiring from active clinical practice in 2006, Dr. Harrison has dedicated his time and research efforts to the PDC, including mentoring junior innovators and trainees and advancing his own device development projects. As the Program Director and Clinical Lead, he oversees PDC activities, strategic aims, and clinical collaborations.

Dr. Harrison has extensive experience in clinical problem-solving and device development, initially in pioneering the field of fetal surgery at UCSF. For more than 25 years, he has studied how life-threatening fetal abnormalities alter normal physical processes. Fetal intervention required the invention of many new techniques and devices, including the development of absorbable staples to open and close the gravid uterus and the development of the Harrison fetal bladder stent for obstructive uropathy. This stent was the first device to receive FDA designation as a Humanitarian Use Device and is widely used around the world.

Earlier in his career, Dr. Harrison developed other novel devices and surgical tools, including a cell microculture harvesting device for automating mixed lymphocycte cultures while a research associate at the NIH. More recently, he has developed devices that rely on magnetic force to solve pediatric problems, two of which are currently in first-in-human trials.

In addition to his role with the PDC, Dr. Harrison is Professor Emeritus of Surgery, Pediatrics, Obstetrics, Gynecology, and Reproductive Sciences and Director Emeritus of the Fetal Treatment Center at UCSF.

#21. Gene DeJuan: Lessons from Founding ForSight Labs

Lessons from Founding ForSight Labs


Gene DeJuan, Jr., MD, Founder & Vice-Chairman, ForSight Labs

#21. EugeneDeJuan-circle.jpg

Renowned retinal surgeon, inventor and entrepreneur Dr. Eugene de Juan, Jr., serves as Vice-Chairman of ForSight Labs, where he participates as an active inventor and advisor in early-stage ophthalmic device opportunities.

Dr. de Juan, Jr., splits his time between ForSight Labs and UCSF. He holds the “Jean Kelly Stock Distinguished Chair” in Ophthalmology. UCSF recruited Dr. de Juan for this special role to augment translation of the many ideas being developed within the academic center. He continues to see patients, operate and teach at UCSF.

Dr. de Juan, Jr., has participated in the development of a number of ophthalmology’s most exciting new technologies with over 100 products and the founding of nine venture funded companies including Second Sight, InnoRx, NeoVista, and Retina Labs, in addition to ForSight Labs’ first five “VISION” companies: Transcend Medical, Inc., founded in 2005; VISION2 (acquired by QLT, Inc. in 2007); Nexis Vision, Inc. (formerly ForSight VISION3, Inc.), founded in 2007; ForSight VISION4, Inc., founded in 2009; and ForSight VISION5, Inc., founded in 2010.

Prior to moving to San Francisco, Dr. de Juan, Jr., was a professor of ophthalmology at the University of Southern California and CEO of the Doheny Eye Institute, focusing on innovative techniques for treating blinding retinal disorders through retinal transplantation, macular translocation, robotic surgery, retinal implants, and other new procedures, medicines and instruments.

Prior to these positions, Dr. de Juan served at the Wilmer Eye Institute at Johns Hopkins University School of Medicine, where he was Co-Director of Vitreoretinal Service, Director of the Microsurgery Advanced Design Laboratory (MADLAB) and Joseph E. Green Professor of Ophthalmology. From 1983 to 1992, he was a member of the medical staff of the Duke University Eye Center, holding joint teaching appointments with the departments of ophthalmology and cell biology.

He is a passionate supporter of ophthalmic education and development and has recently helped established a chair for Ophthalmic Education at Johns Hopkins University.

Dr. de Juan completed his medical degree and internship training at the University of South Alabama College of Medicine. He served an internship at University of South Alabama Medical Center followed by a residency at the Wilmer Ophthalmological Institute in Baltimore, MD, and a fellowship in vitreoretinal surgery at Duke University. He holds patents on over sixty medical devices and is responsible for more than 250 academic publications.

#20. Joe Urban: Detecting Acute Kidney Injury at Potrero Medical

Detecting Acute Kidney Injury at Potrero Medical


Joe Urban, CEO, Potrero Medical

#20 Joe Urban.jpg

Potrero Medical, Inc. is a predictive health company transforming patient care using predictive analytics for early detection of critical illnesses. As a spinout of medical device incubator Theranova LLC, Potrero Medical was founded with a mission to improve patient care with the latest advances in artificial intelligence and machine insights. Potrero Medical is headquartered in San Francisco, CA. For more information, visit www.potreromed.com or follow on LinkedIn.

#19. Amanda French: Smart Birth Control at Cadence Digital

Smart Birth Control at Cadence Digital


Amanda French, Co-Founder and CEO, Cadence Digital

Amanda French.png

Amanda is the co-founder and CEO of Cadence Digital – a reproductive health company focused on empowering women to understand and control their birth control. She was a 2016-2017 Innovation Fellow at the Stanford Byers Center for Biodesign. Amanda began her career at Edwards Lifesciences, where through the Technical Development Program she gained experience in R&D, program management, manufacturing, and marketing. She quickly caught the innovation bug, and enjoyed developing breakthrough technology as an R&D engineer with Edwards’ Advanced Technology teams as well as at Earlens. Amanda holds a BS in mechanical engineering from Duke University. When she is not working, she enjoys cooking, yoga, and contemporary dance.

#18. Carl Schoellhammer: Innovating in Drug Delivery at Suono Bio

Innovating in Drug Delivery at Suono Bio


Carl Schoellhammer, Founder and COO, Suono Bio


A former student of MIT professor Robert Langer, Carl invented a pill that can inject drugs directly into the gastrointestinal tract. His mPill is a small plastic devices covered with tiny needles and a protective coating that dissolves. The invention, platform technology to deliver therapeutic molecules independent of formulation, helped him win the prestigious Lemelson-MIT Student Prize.

About Suono Bio

Suono Bio is developing therapeutic products for inflammatory-mediated diseases leveraging their ultra-rapid and formulation independent delivery technology. Suono Bio’s platform enables rapid, localized delivery of small molecules, biologics, and nucleic acids and gene therapies without the need for encapsulation of the therapeutic. Suono is a portfolio company of the Rosenman Institute’s VC fund, Medtech Venture Partners.

#17. Alex Tilson: Pivoting with Advanced Materials at Loma Vista Medical

Pivoting with Advanced Materials at Loma Vista Medical

Alex Tilson, CEO & Founder, Loma Vista Medical & Neptune Medical

alex tilson.jpeg

Alex Tilson is the founder and CEO of Neptune Medical. Alex has spent the last twenty- five years leading high performance teams that build innovative, world-class products, including solar powered race vehicles (Stanford University, across the U.S. 2x and across Australia), film industry animatronic special effects (Edge Innovations (‘Free Willy’ and ‘Anaconda’)), surgical robotics (Intuitive Surgical), products for interventional cardiology (Guidant), implantable coronary devices (Converge Medical), extended wear hearing aids (InSound Medical), and high performance composite medical balloons (Loma Vista Medical). He is a Stanford mechanical engineer and earned an MBA from Harvard. Alex is an avid cyclist (nine major tours, including across Asia and 4x across North America), and a competitive distance runner (Olympic Trial marathoner and former American 50k record holder (http://www.hogue.com/svclassic/index2002.html)).

#16. Russ Branaghan: How to Use FDA's Guidance on Human Factors

How to Use FDA's Guidance on Human Factors

Russ Branaghan, President & Chief Scientist, Research Collective


Download the slide deck that Russ used while giving this talk.


Dr. Russell J. Branaghan is founder and scientific advisor at Research Collective. Russ enjoys teaching, mentoring and research as a Professor of Cognitive Psychology and Human Factors at Arizona State University and as a long-standing Visiting Professor at Northwestern University. Russ is also integrated in the human factors arena, where he currently serves as Chair of the Human Factors and Ergonomics Society Product Design Technical Group, on the Editorial Board of the Journal of Human Factors, and on the Advisory Board for Mayo Clinic’s Center for Innovation. An avid researcher and writer, Russ has authored over 40 articles and one book. He also served an appointment as the Managing Editor of User Experience Magazine. With over 20 years of industry experience and consulting to over half of the Fortune 100, Russ brings his expertise and vision to Research Collective.